Literature DB >> 8013548

Prolonged tolerance, dependence and abstinence following subcutaneous morphine pellet implantation in the rat.

L H Gold1, L Stinus, C E Inturrisi, G F Koob.   

Abstract

Opiate withdrawal is a common occurrence in human opiate addicts that is no life threatening but is hypothesized to be a significant factor which may contribute to drug taking behavior in these opiate dependent individuals. The purpose of this study was to compare the time course for the development of tolerance, dependence and abstinence using a rat model. Rats were made dependent by implantation of 2 morphine pellets s.c. (75 mg morphine base). Morphine implanted rats exhibited analgesia as measured in a tail-dip assay, for up to 12 h post-implant after which the development of tolerance resulted in tail-flick latencies returning to the level of control rats. Withdrawal was evaluated by injection of the opiate antagonist, naloxone (1 mg/kg s.c.). Rating of the abstinence syndrome revealed significant withdrawal signs by 3 h post-implant which became increasingly intense up to 24 h post-implant. Withdrawal could be precipitated for at least 13 days post-implant, while by 18 days post-implant almost no abstinence signs were observed. Plasma morphine levels following implantation of 2 pellets remained relatively stable from 3-12 days post-implantation. These results further extend the characterization of opiate abstinence following subcutaneous pellet implantation. These results also suggest that opiate abstinence develops within the first 24 h and follows the time course of the development of tolerance. The characterization of the evolution of opiate tolerance, physical dependence and abstinence under similar experimental conditions is critical to the design of future studies to examine the neural bases for these phenomena.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8013548     DOI: 10.1016/0014-2999(94)90755-2

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  38 in total

Review 1.  Paradoxical signal transduction in neurobiological systems.

Authors:  F C Colpaert; Y Frégnac
Journal:  Mol Neurobiol       Date:  2001 Aug-Dec       Impact factor: 5.590

2.  CRF₂ mediates the increased noradrenergic activity in the hypothalamic paraventricular nucleus and the negative state of morphine withdrawal in rats.

Authors:  Javier Navarro-Zaragoza; Cristina Núñez; Jessica Ruiz-Medina; M Luisa Laorden; Olga Valverde; M Victoria Milanés
Journal:  Br J Pharmacol       Date:  2011-02       Impact factor: 8.739

3.  Neuroadaptation of GABAergic transmission in the central amygdala during chronic morphine treatment.

Authors:  Michal Bajo; Marisa Roberto; Samuel G Madamba; George Robert Siggins
Journal:  Addict Biol       Date:  2010-12-23       Impact factor: 4.280

4.  Activation in extended amygdala corresponds to altered hedonic processing during protracted morphine withdrawal.

Authors:  Glenda C Harris; Gary Aston-Jones
Journal:  Behav Brain Res       Date:  2006-11-22       Impact factor: 3.332

5.  Lateral hypothalamic orexin/hypocretin neurons that project to ventral tegmental area are differentially activated with morphine preference.

Authors:  Kimberlei A Richardson; Gary Aston-Jones
Journal:  J Neurosci       Date:  2012-03-14       Impact factor: 6.167

6.  Extinction of conditioned opiate withdrawal in rats in a two-chambered place conditioning apparatus.

Authors:  Karyn M Myers; Anita J Bechtholt-Gompf; Brian R Coleman; William A Carlezon
Journal:  Nat Protoc       Date:  2012-02-23       Impact factor: 13.491

7.  Long-term morphine delivery via slow release morphine pellets or osmotic pumps: Plasma concentration, analgesia, and naloxone-precipitated withdrawal.

Authors:  Virginia D McLane; Ivy Bergquist; James Cormier; Deborah J Barlow; Karen L Houseknecht; Edward J Bilsky; Ling Cao
Journal:  Life Sci       Date:  2017-07-16       Impact factor: 5.037

8.  Anatomically dissociable effects of dopamine D1 receptor agonists on reward and relief of withdrawal in morphine-dependent rats.

Authors:  Elena H Chartoff; Matthew F Barhight; Steve D Mague; Allison M Sawyer; William A Carlezon
Journal:  Psychopharmacology (Berl)       Date:  2009-01-16       Impact factor: 4.530

9.  Ethopharmacological analysis of naloxone-precipitated morphine withdrawal syndrome in rats: a newly-developed "etho-score".

Authors:  E Fdez Espejo; M Cador; L Stinus
Journal:  Psychopharmacology (Berl)       Date:  1995-11       Impact factor: 4.530

10.  Presynaptic dopaminergic function in the nucleus accumbens following chronic opiate treatment and precipitated withdrawal.

Authors:  S Ghosh; K Grasing
Journal:  Neurochem Res       Date:  1999-01       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.